Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. Akratos

Pcn141 - Cost-Effectiveness Analysis of Obinutuzumab for the Treatment of Patients With Previously Untreated Advanced Follicular Lymphoma in Greece

Value in Health

English

Related publications

Ongoing Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma

Hematological Oncology

English

Sakk 35/15: A Phase I Trial of Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients

Hematological Oncology

English

Profile of Obinutuzumab for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia

OncoTargets and Therapy

Oncology

Pharmacology

2015

English

Immunochemotherapy With Obinutuzumab or Rituximab in Previously Untreated Follicular Lymphoma in the Randomised Phase Iii Gallium Study: Analysis by Chemotherapy Regimen

Hematological Oncology

English

Obinutuzumab Plus Bendamustine in Previously Untreated Patients With CLL: A Subgroup Analysis of the GREEN Study

English

Management of Patients With Follicular Lymphoma Treated First Line With Obinutuzumab

Asia-Pacific Journal of Clinical Oncology

Medicine

Oncology

2019

English

Pcn133 - The Societal Impact of Obinutuzumab in the First Line Treatment of Patients With Follicular Lymphoma in Germany

English

Pnd59 - Cost Effectiveness Analysis of Alemtuzumab as a Treatment Option for Patients With Multiple Sclerosis in Greece

English

Pcn83 - The Use of Obinutuzumab in Treatment of Refractory and Relapsing Follicular Lymphoma

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. Akratos

Pcn141 - Cost-Effectiveness Analysis of Obinutuzumab for the Treatment of Patients With Previously Untreated Advanced Follicular Lymphoma in Greece

Related publications

Ongoing Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma

Sakk 35/15: A Phase I Trial of Obinutuzumab in Combination With Venetoclax in Previously Untreated Follicular Lymphoma Patients

Profile of Obinutuzumab for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia

Immunochemotherapy With Obinutuzumab or Rituximab in Previously Untreated Follicular Lymphoma in the Randomised Phase Iii Gallium Study: Analysis by Chemotherapy Regimen

Obinutuzumab Plus Bendamustine in Previously Untreated Patients With CLL: A Subgroup Analysis of the GREEN Study

Management of Patients With Follicular Lymphoma Treated First Line With Obinutuzumab

Pcn133 - The Societal Impact of Obinutuzumab in the First Line Treatment of Patients With Follicular Lymphoma in Germany

Pnd59 - Cost Effectiveness Analysis of Alemtuzumab as a Treatment Option for Patients With Multiple Sclerosis in Greece

Pcn83 - The Use of Obinutuzumab in Treatment of Refractory and Relapsing Follicular Lymphoma